Fig. 5

Time-dependent prediction results for progression-free survival (PFS) after immunotherapy. ROC curves of DeepSurv models based on (a) Clinical Features, (b) Clinical + Intratumoralal Radiomics, and (c) Clinical + Intratumoralal + Peritumoral Radiomics